← Leaderboards
Karen S Aboody
Layton Bioscience, Inc.
$8,965,368
Attributed
$11,392,064
Total exposure
8
Grants
3
Lead (contact PI)
Attributed= this PI's even-split share of every grant they're on (the fair, additive number). Exposure = full size of all those grants.
Funding over time
peak $2.4M · FY2008–19$2.5M$1.9M$1.3M$625K$0
'08
'09
'10
'11
'12
'13
'14
'15
'16
'17
'18
'19
Funding mix
By agency
NIH$10,796,742 · 7
FDA$595,322 · 1
By mechanism
R01$5,457,075 · 4
U01$4,669,355 · 1
R21$730,400 · 1
R44$435,234 · 1
R43$100,000 · 1
Top collaborators
- Jana Portnow10 shared
- Jacob M Berlin4 shared
Others in their field
Top investigators on “Nerve Stem Cell”
- David Heimbrook · Leidos Biomedical Research, Inc.$31,285,017
- Andrew J Saykin · Mayo Clinic Jacksonville$29,806,809
- Steven M Finkbeiner · J. David Gladstone Institutes$24,496,090
- Li-Huei Tsai · Massachusetts Institute Of Technology$20,554,602
- Roberta Diaz Brinton · University Of Arizona$19,643,944
- Arnold Kriegstein · University Of California, San Francisco$18,688,311
Research focus
Nerve Stem CellCellsProdrugsPre-ClinicalToxic EffectTumorEnzymesNeoplasm MetastasisSiteGliomaPharmaceutical PreparationsIn VivoRecurrenceSafetyPropertyCancer TherapyPreventDrug Delivery SystemsClinical TrialsBrainNeoplastic CellNormal Tissue MorphologyIntravenousDose
Grant awards (25)
A Phase I Study of Intracranially Administered Carboxylesterase-Expressing Neural Stem Cells in Combination with Intravenous Irinotecan in Patients with Recurrent High Grade Gliomas$505,496
R01 · FY2019 · CA
Stem Cell/Nanoparticle Constructs for Targeted Ovarian Cancer Therapy$377,208
R01 · FY2019 · CA · contact PI
Stem Cell/Nanoparticle Constructs for Targeted Ovarian Cancer Therapy$66,520
R01 · FY2019 · CA · contact PI
A Phase I Study of Intracranially Administered Carboxylesterase-Expressing Neural Stem Cells in Combination with Intravenous Irinotecan in Patients with Recurrent High Grade Gliomas$546,873
R01 · FY2018 · CA
Stem Cell/Nanoparticle Constructs for Targeted Ovarian Cancer Therapy$388,875
R01 · FY2018 · CA · contact PI
Stem Cell/Nanoparticle Constructs for Targeted Ovarian Cancer Therapy$68,577
R01 · FY2018 · CA
Neural Stem Cell Mediated CE-CPT11 Therapy for Neuroblastoma$949,003
U01 · FY2017 · NS · contact PI
Stem Cell/Nanoparticle Constructs for Targeted Ovarian Cancer Therapy$388,875
R01 · FY2017 · CA
A Phase I Study of Intracranially Administered Carboxylesterase-Expressing Neural Stem Cells in Combination with Intravenous Irinotecan in Patients with Recurrent High Grade Gliomas$1
R01 · FY2017 · CA
Neural Stem Cell Mediated CE-CPT11 Therapy for Neuroblastoma$1,238,896
U01 · FY2016 · NS · contact PI
A Phase I Study of Intracranially Administered Carboxylesterase-Expressing Neural Stem Cells in Combination with Intravenous Irinotecan in Patients with Recurrent High Grade Gliomas$618,770
R01 · FY2016 · CA
Stem Cell/Nanoparticle Constructs for Targeted Ovarian Cancer Therapy$388,875
R01 · FY2016 · CA
Phase 1 Study of Neural Stem Cells & 5-FC/Leucovorin for the Treatment of Recurrent High Grade Gliomas$195,322
R01 · FY2016 · FD
A Phase I Study of Intracranially Administered Carboxylesterase-Expressing Neural Stem Cells in Combination with Intravenous Irinotecan in Patients with Recurrent High Grade Gliomas$621,329
R01 · FY2015 · CA
Stem Cell/Nanoparticle Constructs for Targeted Ovarian Cancer Therapy$388,875
R01 · FY2015 · CA
Phase 1 Study of Neural Stem Cells & 5-FC/Leucovorin for the Treatment of Recurrent High Grade Gliomas$200,000
R01 · FY2015 · FD
Neural Stem Cell Mediated CE-CPT11 Therapy for Neuroblastoma$1,447,960
U01 · FY2014 · NS · contact PI
Phase 1 Study of Neural Stem Cells & 5-FC/Leucovorin for the Treatment of Recurrent High Grade Gliomas$200,000
R01 · FY2014 · FD
Neural Stem Cell Mediated CE-CPT11 Therapy for Neuroblastoma$1,033,496
U01 · FY2013 · NS · contact PI
A Pilot Study of 5-FC and Genetically-Modified Neural Stem Cells to Treat Gliomas$365,200
R21 · FY2010 · CA
A Pilot Study of 5-FC and Genetically-Modified Neural Stem Cells to Treat Gliomas$365,200
R21 · FY2009 · CA
Neural Progenitor Cells as Cancer Therapy Vectors$159,895
R01 · FY2009 · CA · contact PI
Neural Progenitor Cells as Cancer Therapy Vectors$341,584
R01 · FY2008 · CA · contact PI
HUMAN NEURAL STEM CELLS TARGET GENE THERAPY-BRAIN TUMORS$435,234
R44 · FY2001 · CA
HUMAN NEURAL STEM CELLS TARGET GENE THERAPY-BRAIN TUMORS$100,000
R43 · FY2000 · CA